Susquehanna International Group
SRGA

Susquehanna International Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Susquehanna International Group’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-857
Closed -$8K – 14560
2022
Q1 		$8K Sell
857
-1,030
-55% -$15.7K ﹤0.01% 12783
2021
Q4 		$41K Buy
1,887
+1,234
+189% +$33K ﹤0.01% 12655
2021
Q3 		$21K Buy
653
+310
+90% +$11.4K ﹤0.01% 12542
2021
Q2 		$14K Sell
343
-67
-16% -$3.43K ﹤0.01% 12435
2021
Q1 		$27K Buy
+410
New +$28.6K ﹤0.01% 12115
2020
Q4 		– Sell
-1,277
Closed -$69K – 11971
2020
Q3 		$69K Buy
+1,277
New +$97.7K ﹤0.01% 10100
2018
Q3 		– Sell
-353
Closed -$49K – 10573
2018
Q2 		$49K Sell
353
-174
-33% -$23.9K ﹤0.01% 9282
2018
Q1 		$73K Buy
+527
New +$71.7K ﹤0.01% 8829
2017
Q4 		– Sell
-777
Closed -$106K – 10143
2017
Q3 		$106K Buy
777
+70
+10% +$10.6K ﹤0.01% 8336
2017
Q2 		$124K Buy
+707
New +$101K ﹤0.01% 8589

Other funds holding SRGA

AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's SRGA Position: Q3 2022 in Review

Susquehanna International Group sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2022, closing a stake of 48,860 shares — an estimated $167K sold.

Susquehanna International Group first reported a position in SRGA in Q3 2013 and held it in 27 quarters. The position peaked at $502K in Q4 2017. 36 funds tracked by Wall St. Rank hold SRGA as of Q3 2022.

  • Susquehanna International Group reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 48,860 Surgalign Holdings, Inc. Common Stock shares in Q3 2022, an estimated $167K.
  • Susquehanna International Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2013 and held it in 27 quarters.
  • Susquehanna International Group's Surgalign Holdings, Inc. Common Stock position peaked at $502K in Q4 2017.
  • 36 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.